A mathematical model of in vivo methotrexate accumulation in acute lymphoblastic leukemia
暂无分享,去创建一个
Ching-Hon Pui | William E. Evans | Mary V. Relling | M. Relling | C. Pui | W. Evans | R. Ribeiro | J. Panetta | J. Rubnitz | G. Rivera | J. Sandlund | John T. Sandlund | Y. Yanishevski | Raul Ribeiro | John Panetta | Yuri Yanishevski | Jeffrey Rubnitz | Gaston K. Rivera
[1] R. Gelber,et al. Treatment of childhood acute lymphoblastic leukemia: results of Dana-Farber Cancer Institute/Children's Hospital Acute Lymphoblastic Leukemia Consortium Protocol 85-01. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[2] W. Hiddemann,et al. Chemotherapy in 998 unselected childhood acute lymphoblastic leukemia patients. Results and conclusions of the multicenter trial ALL-BFM 86. , 1994, Blood.
[3] B. Camitta,et al. Intensive intravenous methotrexate and mercaptopurine treatment of higher-risk non-T, non-B acute lymphocytic leukemia: A Pediatric Oncology Group study. , 1994, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[4] D. Priest,et al. The role of folylpolyglutamate synthetase and gamma-glutamyl hydrolase in altering cellular folyl- and antifolylpolyglutamates. , 1987, Advances in enzyme regulation.
[5] M. Rots,et al. Role of folylpolyglutamate synthetase and folylpolyglutamate hydrolase in methotrexate accumulation and polyglutamylation in childhood leukemia. , 1999, Blood.
[6] P. Gimotty,et al. Elevated dihydrofolate reductase and impaired methotrexate transport as elements in methotrexate resistance in childhood acute lymphoblastic leukemia. , 1995, Blood.
[7] C. Allegra,et al. Inhibition of phosphoribosylaminoimidazolecarboxamide transformylase by methotrexate and dihydrofolic acid polyglutamates. , 1985, Proceedings of the National Academy of Sciences of the United States of America.
[9] M. Relling,et al. Blast cell methotrexate-polyglutamate accumulation in vivo differs by lineage, ploidy, and methotrexate dose in acute lymphoblastic leukemia. , 1994, The Journal of clinical investigation.
[10] M. Rhee,et al. Characterization of human cellular gamma-glutamyl hydrolase. , 1998, Molecular pharmacology.
[11] R. Gelber,et al. Low-dose versus high-dose methotrexate during remission induction in childhood acute lymphoblastic leukemia (Protocol 81-01 update). , 1991, Blood.
[12] M. Rhee,et al. Effects of gamma-glutamyl hydrolase on folyl and antifolylpolyglutamates in cultured H35 hepatoma cells. , 1995, Molecular Pharmacology.
[13] M. Relling,et al. Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia , 1994 .
[15] J. Coward,et al. Glutamylation of methotrexate in hepatoma cells in vitro: regulation and the development of specific inhibitors. , 1985, Advances in Enzyme Regulation.
[16] D. W. Fry,et al. Analysis of the role of membrane transport and polyglutamation of methotrexate in gut and the Ehrlich tumor in vivo as factors in drug sensitivity and selectivity. , 1983, Cancer research.
[17] M. Relling,et al. Conventional compared with individualized chemotherapy for childhood acute lymphoblastic leukemia. , 1998, The New England journal of medicine.
[18] J. White,et al. Methotrexate resistance in al L1210 cell line resulting from increased dihydrofolate reductase, decreased thymidylate synthetase activity, and normal membrane transport. Computer simulations based on network thermodynamics. , 1981, The Journal of biological chemistry.
[19] S. Raimondi,et al. Reduced folate carrier expression in acute lymphoblastic leukemia: a mechanism for ploidy but not lineage differences in methotrexate accumulation. , 1999, Blood.
[20] J. White,et al. Application of network thermodynamics to the computer modeling of the pharmacology of anticancer agents: a network model for methotrexate action as a comprehensive example. , 1981, Pharmacology & therapeutics.
[21] A. Look,et al. Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1992, Blood.
[22] B. Chabner. Pharmacologic principles of cancer treatment , 1982 .
[23] B. Kamen,et al. Receptor-mediated folate accumulation is regulated by the cellular folate content. , 1986, Proceedings of the National Academy of Sciences of the United States of America.
[24] F. Sirotnak,et al. Hydrolytic cleavage of methotrexate gamma-polyglutamates by folylpolyglutamyl hydrolase derived from various tumors and normal tissues of the mouse. , 1986, Cancer research.
[25] R. Moran. Characterization of the function of mammalian folylpolyglutamate synthetase (FPGS). , 1983, Advances in experimental medicine and biology.
[26] J. Bertino,et al. gamma-Glutamyl hydrolase and folylpolyglutamate synthetase activities predict polyglutamylation of methotrexate in acute leukemias. , 1997, Oncology research.
[27] A. Look,et al. Accumulation of high levels of methotrexate polyglutamates in lymphoblasts from children with hyperdiploid (greater than 50 chromosomes) B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group study. , 1992, Blood.
[28] M. Mazumdar,et al. Defective transport is a common mechanism of acquired methotrexate resistance in acute lymphocytic leukemia and is associated with decreased reduced folate carrier expression. , 1997, Blood.
[29] J. Shuster,et al. Intermediate-dose intravenous methotrexate and mercaptopurine therapy for non-T, non-B acute lymphocytic leukemia of childhood: a Pediatric Oncology Group study. , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[30] R. Murphy,et al. The effect of leucovorin on the synthesis of methotrexate poly-gamma-glutamates in the MCF-7 human breast cancer cell line. , 1985, Biochemical pharmacology.
[31] J. Bertino,et al. Karnofsky memorial lecture. Ode to methotrexate. , 1993, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[32] M. Rhee,et al. Glutamyl hydrolase: properties and pharmacologic impact. , 1999, Seminars in oncology.
[33] J. Bertino,et al. Drug resistance in acute leukemia. , 1993, Leukemia & lymphoma.
[34] M. Relling,et al. Accumulation of methotrexate polyglutamates in lymphoblasts is a determinant of antileukemic effects in vivo. A rationale for high-dose methotrexate. , 1996, The Journal of clinical investigation.
[35] C. Allegra,et al. The kinetics of methotrexate polyglutamation in human breast cancer cells. , 1987, Archives of biochemistry and biophysics.
[36] J. White,et al. Reversal of methotrexate binding to dihydrofolate reductase by dihydrofolate. Studies with pure enzyme and computer modeling using network thermodynamics. , 1979, The Journal of biological chemistry.
[37] C. Pui,et al. Acute lymphoblastic leukemia. , 1998, The New England journal of medicine.
[38] M. Relling,et al. Differences in constitutive and post-methotrexate folylpolyglutamate synthetase activity in B-lineage and T-lineage leukemia. , 1994, Blood.
[39] N. Winick,et al. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial. , 1998, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[40] E. Schneider,et al. Human gamma-glutamyl hydrolase: cloning and characterization of the enzyme expressed in vitro. , 1996, Proceedings of the National Academy of Sciences of the United States of America.
[41] J. Galivan,et al. Regulatory aspects of the glutamylation of methotrexate in cultured hepatoma cells. , 1983, Archives of biochemistry and biophysics.
[42] R. Jackson,et al. Studies with a mathematical model of folate metabolism. , 1973, Archives of biochemistry and biophysics.
[43] J. Bertino,et al. Disparate affinities of antifolates for folylpolyglutamate synthetase from human leukemia cells , 1997 .
[44] G. Peters,et al. Methotrexate resistance in relapsed childhood acute lymphoblastic leukaemia , 2000, British journal of haematology.
[45] D. Rodbard,et al. Enhanced inhibition of thymidylate synthase by methotrexate polyglutamates. , 1985, The Journal of biological chemistry.
[46] J. Shuster,et al. Accumulation of methotrexate and methotrexate polyglutamates in lymphoblasts at diagnosis of childhood acute lymphoblastic leukemia: a pilot prognostic factor analysis. , 1990, Blood.
[47] M. Balińska,et al. Studies of formation and efflux of methotrexate polyglutamates with cultured hepatic cells. , 1983, Advances in experimental medicine and biology.
[48] M. Relling,et al. Differences in folylpolyglutamate synthetase and dihydrofolate reductase expression in human B-lineage versus T-lineage leukemic lymphoblasts: mechanisms for lineage differences in methotrexate polyglutamylation and cytotoxicity. , 1997, Molecular pharmacology.
[49] M. Waltham,et al. Intrinsic and acquired resistance to methotrexate in acute leukemia. , 1996, The New England journal of medicine.
[50] M. Relling,et al. Methotrexate intracellular disposition in acute lymphoblastic leukemia: a mathematical model of gamma-glutamyl hydrolase activity. , 2002, Clinical cancer research : an official journal of the American Association for Cancer Research.